PMA supplement
P250011 S002: ProVee System for BPH
FDA PMA supplement · 30-Day Notice · Proverum, Ltd.
Key facts
| Original PMA | P250011 |
|---|---|
| Supplement number | S002 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | ProVee System for BPH |
| Generic name | STENT, URETHRAL, PROSTATIC, PERMANENT OR SEMI-PERMANENT |
| Applicant | Proverum, Ltd. |
| Product code | MER |
| Received date | May 6, 2026 |
| Decision date | Jun 3, 2026 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: